AU2003267443A8 - Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41) - Google Patents
Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41)Info
- Publication number
- AU2003267443A8 AU2003267443A8 AU2003267443A AU2003267443A AU2003267443A8 AU 2003267443 A8 AU2003267443 A8 AU 2003267443A8 AU 2003267443 A AU2003267443 A AU 2003267443A AU 2003267443 A AU2003267443 A AU 2003267443A AU 2003267443 A8 AU2003267443 A8 AU 2003267443A8
- Authority
- AU
- Australia
- Prior art keywords
- gpr41
- therapeutics
- diagnostics
- protein
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02023795.4 | 2002-10-25 | ||
EP02023795 | 2002-10-25 | ||
PCT/EP2003/011319 WO2004038421A2 (en) | 2002-10-25 | 2003-10-13 | Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41) |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003267443A8 true AU2003267443A8 (en) | 2004-05-13 |
AU2003267443A1 AU2003267443A1 (en) | 2004-05-13 |
Family
ID=32116226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003267443A Abandoned AU2003267443A1 (en) | 2002-10-25 | 2003-10-13 | Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41) |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003267443A1 (en) |
WO (1) | WO2004038421A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006052566A2 (en) * | 2004-11-03 | 2006-05-18 | Arena Pharmaceuticals, Inc. | Gpr41 and modulators thereof for the treatment of insulin-related disorders |
JP2013510834A (en) | 2009-11-16 | 2013-03-28 | メリテク | [1,5] -diazocine derivatives |
AU2013290100A1 (en) | 2012-07-11 | 2015-01-29 | Elcelyx Therapeutics, Inc. | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1255779A2 (en) * | 2000-02-18 | 2002-11-13 | Glaxo Group Limited | Identification of modulators of gpr41 or gpr42 activity |
-
2003
- 2003-10-13 AU AU2003267443A patent/AU2003267443A1/en not_active Abandoned
- 2003-10-13 WO PCT/EP2003/011319 patent/WO2004038421A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004038421A2 (en) | 2004-05-06 |
AU2003267443A1 (en) | 2004-05-13 |
WO2004038421A3 (en) | 2004-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003214249A8 (en) | Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) | |
AU2003214072A1 (en) | Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1) | |
AU2003301894A8 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d) | |
AU2003267443A8 (en) | Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41) | |
AU2003273994A8 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) | |
AU2003276097A8 (en) | Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42) | |
AU2003229767A8 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9) | |
AU2003240589A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 4 (gpr4) | |
AU2003276106A8 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12) | |
AU2003219030A8 (en) | Diagnostics and therapeutics for diseases associated with human g protein-coupled orphan receptor 21 (gpr21) | |
AU2003301892A8 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3) | |
AU2003283266A8 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 14 (gpr14) | |
AU2003250128A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37) | |
AU2003246726A1 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 45 (gpr45) | |
AU2003216866A8 (en) | Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) | |
AU2003279361A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7B (PDE7b) | |
AU2003274005A1 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 6 (gpr6) | |
AU2003229736A1 (en) | Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1) | |
AU2003288251A8 (en) | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor 38 (gpr38) | |
AU2003227751A1 (en) | Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 1 (avpr1) | |
AU2003240639A1 (en) | Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3) | |
AU2003221502A8 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 10 (gpr10) | |
AU2003294728A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2) | |
AU2003227064A8 (en) | Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1) | |
AU2003279322A8 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a3 (pde11a3) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |